Clopitab-A 150 Capsule
By Clopitab-A
Rx
15 Capsule in a Strip

Composition
Aspirin(150mg) + Clopidogrel(75mg)

Manufacturer - Lupin Ltd
Lupin Ltd, 3rd floor Kalpataru Inspire, Off. W E Highway, Santacruz (East), Mumbai 400 055. India

Expires on or after
August, 2026

liver
When using Clopitab-A 150 Capsule, it is important to be cautious if you have liver disease. Patients with liver issues may require dose adjustments when taking Clopitab-A 150 Capsule, so it is advised to consult your doctor before use. It is not recommended to use Clopitab-A 150 Capsule in patients with severe liver disease. If you have any liver concerns, it is best to seek guidance from your healthcare provider before starting this medication.

kidney
Clopitab-A 150 Capsule requires caution in kidney disease. Dose adjustment may be necessary. Avoid in severe kidney disease. Consult your doctor before using.

alcohol
It is not safe to drink alcohol while taking Clopitab-A 150 Capsule.

driving
Clopitab-A 150 Capsule may reduce alertness, impact vision, or induce drowsiness and dizziness. Avoid driving if experiencing these effects.

pregnancy
Clopitab-A 150 Capsule is not safe to use during pregnancy as it poses a definite risk to the developing baby. However, in life-threatening situations, a doctor may prescribe it if benefits outweigh risks. Consult your doctor.

breastfeeding
Clopitab-A 150 Capsule is likely unsafe while breastfeeding. Limited data indicates it may pass into breastmilk and harm the baby.
| Habit Forming | No |
| Chemical Class | - |
| Therapeutic Class | - |
| Action Class | - |
₹120.96
₹134.4
10% OFF
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024






